title: Acute blindness during treatment of recurrent or metastatic nasopharyngeal carcinoma with doxorubicin and CCNU.
authors: J H
authors: JH
authors: Schornagel
authors: J
authors: J
authors: Verweij
authors: P H
authors: PH
authors: de Mulder
authors: J
authors: J
authors: Wildiers
authors: A
authors: A
authors: Kirkpatrick
authors: F
authors: F
authors: Cognetti
mesh_terms: D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D001766:Blindness / Q000139:chemically induced*; D004317:Doxorubicin / Q000009:adverse effects; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008130:Lomustine / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D009303:Nasopharyngeal Neoplasms / Q000188:drug therapy*
chemical_list: D008130:Lomustine; D004317:Doxorubicin